Compound Evidence File
#EC-2026-0129
BMK glycidic acid (free acid) CAS 25547-51-7
Filed under Raw Materials. The bureau holds 143 laboratory returns for this compound from 41 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
41 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Nov 2025 | 27 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 10.0 | 9.9 | 10.0 | 3 Apr 2026 | 11 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 10.0 | 10.0 | 10.0 | 7 Jan 2026 | 14 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 10.0 | 10.0 | 1 Mar 2026 | 26 Apr 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 10.0 | 9.9 | 10.0 | 16 Apr 2026 | 12 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Nov 2025 | 17 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 10.0 | 10.0 | 13 Dec 2025 | 2 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 10.0 | 10.0 | 10.0 | 10 Jan 2026 | 14 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 28 May 2026 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 2 | 10.0 | 10.0 | 10.0 | 17 Apr 2026 | 5 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 10.0 | 10.0 | 10.0 | 27 Mar 2026 | 26 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 10.0 | 10.0 | 10.0 | 7 Jan 2026 | 12 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 10.0 | 10.0 | 10.0 | 11 Mar 2026 | 9 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 23 Dec 2025 | 3 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Nov 2025 | 14 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 13 Jan 2026 | 5 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Jan 2026 | 7 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 22 Feb 2026 | 25 Jun 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 2 Aug 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Dec 2025 | 28 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 3 | 9.9 | 9.9 | 10.0 | 7 Dec 2025 | 24 Jun 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 9.2 | 9.2 | 9.3 | 7 May 2025 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 9.1 | 9.1 | 9.2 | 21 May 2026 | 21 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.5 | 6.8 | 9.2 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.4 | 7.5 | 9.7 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 2 | 8.3 | 8.2 | 8.4 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 5 | 8.0 | 7.4 | 9.0 | 23 May 2026 | 23 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 8.0 | 6.7 | 9.3 | 25 Apr 2025 | 24 May 2026 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 | 13 Jun 2025 |
| HK PeptidesCASE #VI-2026-0140 | X | 15 | 7.1 | 2.5 | 10.0 | 2 Jul 2025 | 20 May 2026 |
| ZZQ PeptidesCASE #VI-2026-0550 | X | 1 | 7.0 | 7.0 | 7.0 | 13 Feb 2025 | 13 Feb 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 14 | 6.9 | 3.6 | 9.5 | 3 Jul 2025 | 20 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 6.3 | 6.3 | 6.3 | 28 Mar 2025 | 28 Mar 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.0 | 5.1 | 6.9 | 28 Mar 2025 | 17 May 2026 |
| Haikou Mingheng TechnologyCASE #VI-2026-0250 | X | 1 | 5.8 | 5.8 | 5.8 | 13 Jun 2025 | 13 Jun 2025 |
| Shaanxi Dideu MedichemCASE #VI-2026-0499 | X | 1 | 5.6 | 5.6 | 5.6 | 27 Feb 2025 | 27 Feb 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 5.4 | 5.4 | 5.4 | 13 Jun 2025 | 13 Jun 2025 |
| Liberty PeptidesCASE #VI-2026-0416 | X | 1 | 5.3 | 5.3 | 5.3 | 24 Apr 2025 | 24 Apr 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 3.1 | 2.8 | 3.4 | 8 Jul 2025 | 19 Jan 2026 |
Open any subject to view the batch-level evidence for BMK glycidic acid (free acid) CAS 25547-51-7 alone.